4 withdrawn. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Withdrawn 4 |
| Phase 1 | 2 | Withdrawn 2 |
Follow COVI-AMG: new trials by email Literature Review of COVI-AMG trials Research Report on COVI-AMG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Hospitalized Adults With COVID-19 COVI-AMG, Placebo - Covid19 | Phase 2 | Withdrawn | Sorrento Therapeutics, Inc. | 2021-04-01 | 2022-08-16 | |
| Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) to Treat COVID-19 COVI-AMG, Placebo - Covid19 | Phase 1 / Phase 2 | Withdrawn | Sorrento Therapeutics, Inc. | 2021-04-01 | 2022-02-25 | |
| Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms COVI-AMG, Placebo - Covid19 | Phase 2 | Withdrawn | Sorrento Therapeutics, Inc. | 2021-04-01 | 2022-02-25 | |
| Study to Evaluate the Safety, Pharmacokinetics and Efficacy of STI-2020 (COVI-AMG™) in Outpatients With COVID-19 COVI-AMG, Placebo - Covid19 | Phase 1 / Phase 2 | Withdrawn | Sorrento Therapeutics, Inc. | 2020-12-01 | 2021-02-12 |
COVID-19 (4)
Sorrento Therapeutics, Inc. (4)
United States (2)
Mike Royal, MD (4)